The BNF updated their website but the information about frequency remains the same Hydroxocobalamin
How does the Precision Peptide Genetic Test relate to your GLP-1 pathway
BPC 157's anti-inflammatory characteristics may offer relief from the mild, chronic inflammation frequently observed in individuals who are overweight or obese
A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region
That comes from a different trial: the Phase 1 single-dose study in lean participants, where -hydroxybutyrate started below the assays detection floor and reached 708 mol/L at 4.5 mg by day 8 a large, dose-ordered rise in a lean cohort. The MASLD substudy, by contrast, found ketones moving only at 4 mg and above in a group with insulin resistance damping the readout
The fears are based on mechanism and animal data, not observed human cancer cases simply because BPC-157 hasnt been studied in humans long enough or in enough people to see those outcomes